OR1A2, commonly known as olfactory receptor family 1 subfamily A member 2, is a protein-coding gene that plays a pivotal role in the intricate processes of olfaction. As a member of the extensive olfactory receptor (OR) family, OR1A2 is integral to the perception and discernment of a wide array of odors. Olfactory receptors such as OR1A2 are specialized proteins located on olfactory sensory neurons within the nasal epithelium. Upon binding to specific odorant molecules, these receptors initiate a neuronal response that culminates in the perception of distinct odors. Structurally, OR1A2 is characterized by a 7-transmembrane domain, a hallmark feature of the G-protein-coupled receptor (GPCR) superfamily. This architecture allows it to interact with G-proteins and instigate intracellular signaling cascades upon activation. The vast repertoire of olfactory receptors, including OR1A2, underscores the capability of the olfactory system to discern a myriad of odorant molecules, each activating a unique combination of receptors, facilitating the complex perception of smells.
Inhibitors targeting OR1A2 are molecules designed to modulate, often reduce, the activity of this specific olfactory receptor. Given the GPCR nature of OR1A2, these inhibitors can act via diverse mechanisms. Some might directly block the receptor's ligand-binding domain, preventing odorant molecules from initiating a response. Others might influence the receptor's ability to undergo conformational changes essential for activating downstream signaling pathways. Yet, others may act on the receptor's interactions with intracellular components, such as G-proteins, thereby modulating the downstream effects triggered by receptor activation. This multi-faceted approach to inhibition ensures that the receptor's activity can be finely tuned, whether to study its biology or to explore broader physiological implications. The vast and intricate family of GPCRs, to which OR1A2 belongs, offers a plethora of targets and interactions, allowing for a wide range of inhibitors, each with unique properties and mechanisms of action.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Pertussis toxin inhibits G-protein coupling in many GPCRs. While it's not specific to olfactory receptors, it may modulate OR1A2 by inhibiting its downstream G-protein signaling cascade. | ||||||
NF 023 | 104869-31-0 | sc-204124 sc-204124A | 10 mg 50 mg | $161.00 $629.00 | 1 | |
NF023 is a selective antagonist for G-protein α-subunits. It may impact OR1A2 signaling by inhibiting G-protein activation and subsequent intracellular signaling. | ||||||
VU 0238429 | 1160247-92-6 | sc-301975 sc-301975A | 5 mg 25 mg | $74.00 $297.00 | ||
VU 0238429 is a known antagonist for certain GPCRs. It may non-specifically modulate OR1A2 function by blocking receptor-ligand binding or interfering with downstream signaling. | ||||||
YM 254890 | 568580-02-9 | sc-507356 | 1 mg | $510.00 | ||
YM-254890 is a selective Gq/11 protein inhibitor. If OR1A2 couples to Gq/11 proteins, this compound can inhibit its downstream signaling cascade. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
SecinH3 is a selective inhibitor of cytohesins, which regulate GPCR signaling. It may indirectly affect OR1A2 by modulating G-protein signaling pathways. | ||||||
Tyrphostin AG 1478 | 175178-82-2 | sc-200613 sc-200613A | 5 mg 25 mg | $96.00 $421.00 | 16 | |
AG 1478 is a tyrosine kinase inhibitor that might indirectly impact GPCR function, including OR1A2, by modulating downstream effector pathways. | ||||||
L-NG-Nitroarginine Methyl Ester (L-NAME) | 51298-62-5 | sc-200333 sc-200333A sc-200333B | 1 g 5 g 25 g | $48.00 $107.00 $328.00 | 45 | |
L-NAME is a nitric oxide synthase inhibitor. GPCR signaling can sometimes modulate nitric oxide pathways, so this might indirectly affect OR1A2 signaling. | ||||||